NLRP3 and hyperuricemia: Studies have found that hyperuricemia exacerbates periodontitis and gouty arthritis by activating NLRP3 (Wu et al., 2025; Sun et al., 2025), suggesting a close link between metabolic abnormalities and inflammation, and indicating that NLRP3 inhibitors could be therapeutic for such conditions.